SCHEMBL4684358

SCHEMBL4684358

CC1(C)CCc2nc(-c3ncc(-c4cccc(F)c4)s3)ccc2C1=O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 3/20 0.40
WRN Q14191 1/20 0.37
RARB P10826 1/20 0.35
RARG P13631 1/20 0.35
HSD17B2 P37059 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
HSD17B1 P14061 1/20 0.34
MAP3K5 Q99683 1/20 0.33
TRPM8 Q7Z2W7 3/20 0.33
PARP10 Q53GL7 1/20 0.33
PARP11 Q9NR21 1/20 0.33
ADORA3 P0DMS8 1/20 0.32
DHODH Q02127 1/20 0.32
CYP1A2 P05177 1/20 0.32
MAPKAPK2 P49137 1/20 0.32
PRKDC P78527 1/20 0.32
ALPL P05186 1/20 0.31
ALPI P09923 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4679273 0.93 DHODH (0.41) GRM5WRNHSD17B2CYP3A4CYP2C9
SCHEMBL13706998 0.90 GRM5 (0.48) GRM5RARBRARGHSD17B2CYP3A4
SCHEMBL4680586 0.89 GRM5 (0.49) GRM5RARBRARGHSD17B2CYP3A4
SCHEMBL8242656 0.88 GRM5 (0.40) GRM5RARBRARGHSD17B2CYP3A4
SCHEMBL4741602 0.87 GRM5 (0.39) GRM5RARBRARGHSD17B2HSD17B1
SCHEMBL4683122 0.86 GRM5 (0.36) GRM5WRNCYP1A2PRKDC
SCHEMBL4683018 0.86 GRM5 (0.38) GRM5RARBRARGMAP3K5
SCHEMBL4680546 0.86 GRM5 (0.44) GRM5
SCHEMBL4679375 0.85 GRM5 (0.35) GRM5RARBRARGPRKDC
SCHEMBL4680082 0.85 GRM5 (0.41) GRM5WRNCYP3A4PARP10PARP11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1943247-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Merz Pharma GmbH & Co.KGaA (DE) 2008-07-16 EP claimed
WO-2007023245-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-03-01 WO claimed
US-20060004001-A1 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors MERZ PHARMA GMBH & CO., KGAA (DE) 2006-01-05 US claimed
EP-1943247-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Merz Pharma GmbH & Co.KGaA (DE) 2008-07-16 EP disclosed
WO-2007023245-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-03-01 WO disclosed
WO-2007023245-A1 TETRAHYDROQUINOLINONES AND THEIR USE AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-03-01 WO disclosed
US-20060004001-A1 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors MERZ PHARMA GMBH & CO., KGAA (DE) 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004001-A1 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors GRM1, GRM5, GRM2 GRM5 2/4885WRN 4767/4885RARB 2353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.